17th Jan 2025 12:55 pm |
RNS |
Holding(s) in Company |
16th Jan 2025 3:42 pm |
RNS |
Martin Murphy appointed as Non-Executive Director |
16th Jan 2025 3:42 pm |
RNS |
Result of General Meeting and Total Voting Rights |
15th Jan 2025 5:37 pm |
RNS |
£18m raised to fund Phase 2 INVENT clinical trial |
20th Dec 2024 7:00 am |
RNS |
Proposed Fundraising |
30th Oct 2024 6:09 pm |
RNS |
Exercise of Share Options and Total Voting Rights |
10th Oct 2024 5:05 pm |
RNS |
Results of AGM and Appointment of New Chairman |
26th Sep 2024 7:00 am |
RNS |
Interim Results |
18th Sep 2024 7:00 am |
RNS |
Appointment of New Chairman and Notice of AGM |
5th Sep 2024 7:00 am |
RNS |
Board Change |
27th Jun 2024 7:00 am |
RNS |
2023 Full Year Results |
15th Nov 2023 7:00 am |
RNS |
Grant of Options |
11th Oct 2023 7:00 am |
RNS |
Appointment of New Chief Financial Officer |
3rd Oct 2023 7:00 am |
RNS |
Appointment of Chief Medical Officer |
21st Sep 2023 7:00 am |
RNS |
Interim Results |
29th Jun 2023 6:02 pm |
RNS |
Result of AGM |
29th Jun 2023 10:00 am |
RNS |
Annual General Meeting Presentation |
22nd Jun 2023 7:00 am |
RNS |
Grant of Options |
23rd May 2023 7:00 am |
RNS |
Posting of Annual Report and Notice of AGM |
27th Apr 2023 7:00 am |
RNS |
2022 Full Year Results |
17th Apr 2023 7:00 am |
RNS |
Notice of Full Year results |
13th Mar 2023 4:40 pm |
RNS |
Second Price Monitoring Extn |
13th Mar 2023 4:35 pm |
RNS |
Price Monitoring Extension |
3rd Feb 2023 4:40 pm |
RNS |
Second Price Monitoring Extn |
3rd Feb 2023 4:35 pm |
RNS |
Price Monitoring Extension |
17th Jan 2023 4:35 pm |
RNS |
Price Monitoring Extension |
13th Jan 2023 4:40 pm |
RNS |
Second Price Monitoring Extn |
13th Jan 2023 4:35 pm |
RNS |
Price Monitoring Extension |
23rd Dec 2022 11:30 am |
RNS |
SPRINTER Trial Results Published |
14th Dec 2022 4:35 pm |
RNS |
Price Monitoring Extension |
1st Dec 2022 7:00 am |
RNS |
Board Changes |
7th Nov 2022 4:40 pm |
RNS |
Second Price Monitoring Extn |
7th Nov 2022 4:35 pm |
RNS |
Price Monitoring Extension |
3rd Nov 2022 4:40 pm |
RNS |
Second Price Monitoring Extn |
3rd Nov 2022 4:35 pm |
RNS |
Price Monitoring Extension |
20th Oct 2022 4:35 pm |
RNS |
Price Monitoring Extension |
6th Oct 2022 1:35 pm |
RNS |
Holding(s) in Company |
4th Oct 2022 7:02 am |
RNS |
Data from the US NIH-led ACTIV-2 Phase 2 trial |
29th Sep 2022 7:01 am |
RNS |
Board Changes |
29th Sep 2022 7:00 am |
RNS |
Interim Results |